LENZ - LENZ Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

LENZ is currently covered by 4 analysts with an average price target of $18.89. This is a potential upside of $15.92 (536.03%) from yesterday's end of day stock price of $2.97.

LENZ Therapeutics's activity chart (see below) currently has 29 price targets and 35 ratings on display. The stock rating distribution of LENZ is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 43.49% of the time, taking 75.62 days on average.

Highest price target for LENZ is $38, Lowest price target is $5, average price target is $18.89.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 29-Oct-2026. First documented stock forecast 26-Mar-2024.

Currently out of the existing stock ratings of LENZ, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2024

$16

$13.03 (438.72%)

$38

22 days ago
(29-Oct-2026)

6/14 (42.86%)

$12.95 (424.59%)

177

Hold Since 11-Aug-2026

$5

$2.03 (68.35%)

$7

1 months 2 days ago
(18-Oct-2026)

0/5 (0%)

$1.7 (51.52%)

Buy Since 14-Apr-2025

$12

$6.18 (106.19%)

$51

6 months 9 days ago
(12-May-2026)

0/2 (0%)

$4.09 (51.71%)

Buy Since 14-Aug-2024

$20

$17.03 (573.40%)

$26

6 months 9 days ago
(11-May-2026)

5/8 (62.5%)

$12.09 (152.84%)

135

Buy Since 03-Feb-2026

$29

$26.03 (876.43%)

$35

7 months 27 days ago
(24-Mar-2026)

0/2 (0%)

$19.93 (219.74%)

Show more analysts

Please expand the browser size to see the chart

What is LENZ (LENZ Therapeutics) average time for price targets to be met?

On average it took 76 days for the stock forecasts to be reached, with an average price target met ratio of 43.49%.

Which analyst most recently updated their price target on LENZ (LENZ Therapeutics)?

Matthew Caufield

Which analyst has the most public recommendations on LENZ (LENZ Therapeutics)?

Matthew Caufield has 17 price targets and 18 ratings on LENZ

Which analyst is the currently most bullish on LENZ (LENZ Therapeutics)?

Gary Nachman with the highest potential upside of $47.03

Which analyst is the currently most reserved on LENZ (LENZ Therapeutics)?

Biren Amin with the lowest potential downside of $2.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?